SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-21-000127
Filing Date
2021-02-02
Accepted
2021-02-02 17:27:26
Documents
2
Group Members
ARUN KUMAR PILLAIGHIATH M. SUKHTIANGMS VENTURES & INVESTMENTS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 13 ss191326_sc13da.htm SC 13D/A 95492
2 JOINT FILING AGREEMENT ss191326_ex9901.htm EX-99.1 6700
  Complete submission text file 0000947871-21-000127.txt   103940
Mailing Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852
Business Address 4260 U.S. ROUTE 1 MONMOUTH JUNCTION NJ 08852 6096193990
Outlook Therapeutics, Inc. (Subject) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-89495 | Film No.: 21582837
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877
Business Address 36 ROBINSON ROAD, #13-01 CITY HOUSE SINGAPORE U0 068877 962 6 582 7999
BioLexis Pte Ltd. (Filed by) CIK: 0001716335 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A